Vol. 21 • Na. N1 • February 2019

In this issue:

• Improving Response Capacities in Opioid Overdose Management
  Cozzolino E., D'Egidio P.F., De Facci R., Leonardi C., Nava F., Stella L., and Maremmani I.
• An Analysis of Psychological and Physical Problems Faced by Drug (Barsh) Addicts in Khyber Pakhtunkhwa, Pakistan
  Jan S.U.K., and Ali A.
• Practitioners' Experiences of Working with Dual Users of Heroin and Crack Cocaine. A Thematic Analysis
  Heidebrecht F., and Macleod M.B.
• Early Maladjustment Schemas in Opioid Abstainers, Opioid Abusers and Normal Individuals
  Veiskarami H.A., Mirdrikvand F., Khodarahimi S., and Rahmian Bougar M.
• Hepatitis C Virus (Hcv) Screening in People Who Inject Drugs (Pwid) and Prisoners - a Narrative Review of Extant Literature
  Crowley D., Cullen W., Lambert J., and Van Hout M.C.
• How to Improve a Poorly Running Agonist Opioid Treatment (Aot). Part 6: psychosocial Care
  Ulmer A., and Meinhold C.

Vol. 21 • Na. N2 • April 2019

In this issue:

• Hepatitis C Treatment and Prevention in Pwid and Prisoners: A Narrative Review of the Extant Literature.
  Crowley D., Cullen W., Lambert J., and Van Hout M.C.
• Over the Counter (Otc) Analgesic Misuse: One Patient's Journey
  Hill D., and Stewart E.
• Early Age of First Drug Misuse Is Associated with Increased Risk of Suicide Attempt by Overdose Amongst Patients with Heroin Addiction in Medication-Assisted Treatment Programmes
  Kastelic A., Pregelj P., Zaman R., and Segrec N.
• Hepatitis C Screening in Inpatient Addiction Treatment Settings in Istanbul Turkey: Implications for Integrating Treatment Services
  Alaei A., Mishkin K., Alaei K., Bilici R., Altintas M., and Altice F.
• Surviving in the Workplace: Conditions in Centres for the Prevention and Treatment of Drug Addiction
  Ignjatova L.
• Does Impulsivity Increase the Risk of Developing a Pathological Condition?
  Conversano C., Marchi L., Ciacchini R., Bertolucci I., Micheloni T., and Maremmani A.G.I.

Vol. 21 • Na. N3 • June 2019

In this issue:

• Relationship between Syringe Sharing and Severity of Psychopathology, Antisocial Personality Disorder and Novelty Seeking in a Sample of Patients with Heroin Use Disorder
  Alnıak İ., Karabulut V., Evren C., Çetin T., Umut G., Ağaçhanlı R., and Evren B.
• Self-Reported Adverse Experiences and Age of Opioid Onset for First Time Admitted to Opioid Maintenance Treatment
  Carlsen S.-E.L., and Torsheim T.
• Using Medication Assisted Treatment to Treat Opioid Use Disorder: Learning from Past Experience to Guide Policy
  Parrino M.
• Low Mindfulness Trait Associated with High Perceived Stress Equally by Methadone Maintenance Treatment Patients and Medical Students
  Claman A., Adelson M., Sason A., Barkay G., and Peles E.
• Difficulties in Initiating Hepatitis C Treatment in Patients with Opioid Use Disorder: Patient's Perspective
  Palma-Alvarez R.F., Ros-Cucurull E., Grau-López L., Martínez-Luna N., Rodríguez-Cintas L., Álvarez A.I., and Roncero C.
• Towards a Specific Psychopathology of Substance Use Disorder: Comparison between Heroin Use Disorder and Chronic Psychotic Patients
  Rugani F., Paganin W., Maremmani A.G.I., Perugi G., and Maremmani I.

Vol. 21 • Na. N4 • August 2019

In this issue:

• Association of Drd2 Gene Polymorphism with Heroin Dependence.
  Koijam A.S., and Haobam R.
• The Effect of Heroin, Cannabis and Cocaine Addiction on Sexual Functions and Depression of Women: A Comparative Cross-Sectional Study
  Dişsiz M.
• Risk of Hepatitis C Virus Infection among Heroin and Methamphetamine Users
  Okruhlica L., and Kamendy Z.
• Cross-Sectional Study on the Need to Provide Contraceptive Services to Women Attending Opioid-Substitution Therapy
  Olioff J., O Shea T., Horan A., Naughton A.M., and O'Brien D.
• Ethnicity and Specific Psychopathology of Addiction. Comparison between Slovenian and Italian Heroin Use Disorder Patients
  Maremmani A.G.I., Lovrecic M., Lovrecic B., and Maremmani I.
• Additional Comments to Staub Et Al., “How to Develop and Implement an Exercise Programme in a Heroin-Assisted Treatment Setting”
  Muller A.E., and Roessler K.K.

Vol. 21 • Na. N5 • October 2019

In this issue:

• The European Medical Agency and the Unfolding Destiny of Alcohol Use Disorder Patients
  Maremmani I.
• Toward Diagnostic and Therapeutic Relativism in Psychiatry and Addiction Medicine
  Mendelevich V.
• A Systematic Review of Methadone Maintenance Therapy Studies in Preventing Relapses in Addiction: Evidence from Asean Countries
  Mohd Fahami N.A., Nazrun Shuid A., Abdullah A., Naina-Mohamed I., Chin K.-Y., Mohamed N., Masbah N., Haji Mohd Saad Q., Kamisah Y., and Muhammad N.
• The Impact of Mindfulness-Based Relapse Prevention on Craving, Lapse and Mindfulness Fostering in Addicted Patients in Methadone Maintenance Treatment
  Sarami Foroushani N.
• Cardiological Safety in Patients Receiving Methadone Treatment
  Farina G., Mungai F., and Starace F.
• How Probation Affects Treatment of Opioid Use Disorders: Comparison of Early Remission Rates between Opioid Use Disorder Patients Admitted to Medical Clinic Voluntarily and by Probation
  Asan Ö., Şahiner İ.V., Şahiner Ş.Y., and Göka E.
• Ethnicity and Specific Psychopathology of Addiction. Comparison between Migrant and Italian Heroin Use Disorder Patients
  Carbone M.G., Tagliarini C., Ricci M., Lupi A.M., Sarandrea L., Ceban A., Casella P., and Maremmani I.

Vol. 21 • Na. N6 • December 2019

In this issue:

• Gender Comparison in the History of Addiction, Specific Psychopathology, Behavioural Covariates of Heroin Craving, and Heroin Post-Traumatic Stress Disorder Spectrum During Agonist Opioid Treatment
  Bronzina V., Conversano C., Maremmani A.G.I., Lamanna F., Pacini M., and Maremmani I.
• Intravenous Abuse of Naphazoline and Heroin Mixture, a Case Report
  Kordrostami R., Akhgari M., and Ameri M.
• Adherence, Abstinence and Quality of Life in Patients with Heroin Dependence Receiving Methadone or Buprenorphine-Naloxone Replacement Therapy
  Pérez V., Hidalgo M.J., Martínez M., Orozco D., and Girón M.
• A Clinical Case Control Study to Evaluate Oxidative Stress in Heroin Addicts
  Ullah A., Khan A., Iqbal Z., Khan I., Ahmad L., Kaleem W.A., Alam M., Ullah N., and Ahmad M.
• Identification of Humoral Immune Indicators in Some Clinical Manifestations in Patients with Heroin Use Disorder without Hepatitis C Infection
  Simonovska N., and Zafirova-Ivanovska B.
• Avoiding the “Wrong Door Syndrome”. The Experience of Dual Disorder Unit in Catanzaro, Italy, Eu
  Insardà A.